https://www.selleckchem.com/pr....oducts/linderalacton
Objective Several clinical trials have suggested that autophagy inhibition is a promising approach for cancer therapy. However, the implications of autophagy in ameloblastoma (A remain undiscovered. This study investigated the dysregulated autophagy and its regulatory mechanisms in AB. Methods The expression and distribution of autophagy-related proteins including B-cell lymphoma-2-interacting protein-1 (Beclin1), microtubule-associated protein 1 light chain 3 (LC3) II/I and lysosomal associated membrane protein 2 (LAMP2) were
Like
Comment
Share
